PCN89 DRUG UTILIZATION PATTERNS AND COSTS FOR ERYTHROPOIESIS-STIMULATING AGENTS (ESAS) IN A MANAGED CARE CANCER POPULATION RECEIVING CHEMOTHERAPY
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70265-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)70265-5/fulltext
Section Title :
Section Order :
918
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70265-5&doi=10.1016/S1098-3015(10)70265-5